Moffitt Cancer Center and SPEROS Announce Hope Innovation District
Moffitt Cancer Center and its wholly owned subsidiary SPEROS, announced the formation of the Hope Innovation District, a community development...
See what others are saying about us.
Speros Taps Embarc, Regional Partners to Launch Radiopharmaceutical Hub
Speros and Moffitt Cancer Center are pushing to transform Tampa Bay into a national hub for radiopharmaceutical development, manufacturing and precision oncology with a new regional coalition.
Proton Therapy is Finally Coming to Tampa Bay Cancer Care
The Richard M. Schulze Family Foundation Proton Therapy Center will use one of the world's largest proton therapy manufacturers' systems, IBA's ProteusONE.
Moffitt Cancer Center Opens First Building at Speros Campus
The 120,000-square-foot outpatient center's opening marks major milestone for one of the region's most ambitious development projects.
Josh Carpenter Says Moffitt's Speros Campus Will Make Tampa Bay a Biotech Hub
The president of Speros discusses strategies for uniting clinical expertise, research and commercial interests at Moffitt's expansive new campus.
Moffitt and Speros Partner with Cryoport
Moffitt Cancer Center, along with Speros, has formed a strategic partnership with Cryoport, which will bring CRYOGENE’s biorepository services to Speros in Pasco County.
If you did not find the information you were seeking in Spanish or would like to schedule an appointment, please call us at 1-888-663-3488.
Thank you.
